Daito Pharmaceutical
4577.TSE
13.59 USD
0.12
+0.89%
d
Overview
Last close
13.59 usd
Market cap
207.91M usd
52 week high
16.60 usd
52 week low
11.77 usd
Target price
18.57 usd
Valuation
P/E
10.3347
Forward P/E
N/A
Price/Sales
0.6536
Price/Book Value
0.5885
Enterprise Value
258.44M usd
EV/Revenue
0.8167
EV/EBITDA
4.8785
Key financials
Revenue TTM
316.62M usd
Gross Profit TTM
69.02M usd
EBITDA TTM
48.56M usd
Earnings per Share
1.38 usd
Dividend
0.4 usd
Total assets
560.47M usd
Net debt
50.96M usd
About
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
- Symbol4577.TSE
- ExchangeTSE
- IsinJP3486150000
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEO
- HeadquarterToyama
- Web sitehttps://www.daitonet.co.jp
